Here’s a look at what Robert F. Kennedy Jr. has said and done since becoming the nation’s top health official on Feb. 13.

A common drug used for inflammatory skin conditions may hold the key to treating both alcohol addiction and pain sensitivity.

After decades of research, the U.S. Food and Drug Administration (FDA) has approved a test that can detect the buildup of amyloid plaques in the brain—a key marker of Alzheimer’s disease, ...

The U.S. Food and Drug Administration said on Friday it had eliminated risk evaluation and mitigation strategies (REMS), a ...

The J.M. Smucker Co. joined a growing list of food giants that are pledging to eliminate FD&C artificial dyes from its products within the next two years.

The agency will allow BMS to discontinue REMS programs for both therapies and reduce certain patient monitoring requirements.

Bristol Myers (BMY) receives FDA approval for label updates for Breyanzi and Abecma, that can ease access to the cancer cell ...

The agency removed some onerous requirements for the complex cancer drugs and reduced restrictions on patients’ ...

Label updates have been approved by the FDA for the CAR T-cell therapies Breyanzi and Abecma in large B cell lymphoma and ...

The Breyanzi REMS program and the Abecma REMS program were established due to the risk of cytokine release syndrome and neurologic toxicities.

In a first step toward FDA approval of kidney xenotransplantation, a living human with end-stage kidney disease may receive a ...

Though much of the dust has settled around Novo Nordisk and Eli Lilly’s crusade against compounded GLP-1s, the recent ...